Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S287626-5mg | 5mg | In stock | $107.90 | |
S287626-10mg | 10mg | In stock | $177.90 | |
S287626-25mg | 25mg | In stock | $375.90 | |
S287626-50mg | 50mg | In stock | $632.90 | |
S287626-100mg | 100mg | In stock | $1,038.90 |
Selective TRPV2 antagonist
Synonyms | SET2 | 2313525-20-9 | N-(furan-2-ylmethyl)-3-[4-[methyl(propyl)amino]-6-(trifluoromethyl)pyrimidin-2-yl]sulfanylpropanamide | TRPV2 antagonist SET2 | SET 2 | CHEMBL4519204 | GTPL12547 | DTXSID101336558 | AKOS040755628 | BS168256 | MS-26855 | HY-132222 | CS-0179805 | N-(Furan-2-ylm |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | TRPV2 (transient receptor potential vanilloid type 2) antagonist (IC50= 0.46 μM). Selective for TRPV2 over TRPV1, TRPV3 and TRPV4 expressed in HEK293 cells. Inhibits lyosphosphatidic acid (LPA)-induced prostate cancer cell migrationin vitro. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | CHANNEL BLOCKER |
Mechanism of action | Channel blocker of TRPV2 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Pubchem Sid | 488203091 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488203091 |
IUPAC Name | N-(furan-2-ylmethyl)-3-[4-[methyl(propyl)amino]-6-(trifluoromethyl)pyrimidin-2-yl]sulfanylpropanamide |
INCHI | InChI=1S/C17H21F3N4O2S/c1-3-7-24(2)14-10-13(17(18,19)20)22-16(23-14)27-9-6-15(25)21-11-12-5-4-8-26-12/h4-5,8,10H,3,6-7,9,11H2,1-2H3,(H,21,25) |
InChi Key | LZHSWRWIMQRTOP-UHFFFAOYSA-N |
Canonical SMILES | CCCN(C)C1=NC(=NC(=C1)C(F)(F)F)SCCC(=O)NCC2=CC=CO2 |
Isomeric SMILES | CCCN(C)C1=NC(=NC(=C1)C(F)(F)F)SCCC(=O)NCC2=CC=CO2 |
PubChem CID | 155541857 |
Molecular Weight | 402.44 |
PubChem CID | 155541857 |
---|---|
ChEMBL Ligand | CHEMBL4519204 |
CAS Registry No. | 2313525-20-9 |
PubChem SID | 488203091 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
D2307772 | Certificate of Analysis | Feb 20, 2023 | S287626 |
D2307773 | Certificate of Analysis | Feb 20, 2023 | S287626 |
D2307779 | Certificate of Analysis | Feb 20, 2023 | S287626 |
D2307780 | Certificate of Analysis | Feb 20, 2023 | S287626 |
D2307857 | Certificate of Analysis | Feb 20, 2023 | S287626 |
D2307858 | Certificate of Analysis | Feb 20, 2023 | S287626 |
D2307868 | Certificate of Analysis | Feb 20, 2023 | S287626 |
D2307869 | Certificate of Analysis | Feb 20, 2023 | S287626 |
D2307870 | Certificate of Analysis | Feb 20, 2023 | S287626 |
D2307874 | Certificate of Analysis | Feb 20, 2023 | S287626 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 40.24, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 20.12, Max Conc. mM: 50 |
---|
1. Chai H, Cheng X, Zhou B, Zhao L, Lin X, Huang D, Lu W, Lv H, Tang F, Zhang Q et al.. (2019) Structure-Based Discovery of a Subtype-Selective Inhibitor Targeting a Transient Receptor Potential Vanilloid Channel.. J Med Chem, 62 (3): (1373-1384). [PMID:30620187] |